EUVIMEDEUVIMED entdecken
Kommentar

Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?

Michelle B Mulder, Quan-Yang Duh

JAMA Surgery · 2023

DOI: 10.1001/jamasurg.2022.5790 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Surgery, 2023. Verfasst von Michelle B Mulder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, San Francisco. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroidectomyThyroid NeoplasmsHumansThyroid Cancer, PapillaryLymphatic MetastasisLymph NodesRetrospective StudiesNeck DissectionLymph Node Excision

Autor:innen und Institutionen

  • Department of Surgery, University of California, San Francisco.

Zitieren

APA

Mulder, M. B., & Duh, Q. Y. (2023). Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.5790

Vancouver

Mulder MB, Duh QY. Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?. JAMA Surgery. 2023. doi:10.1001/jamasurg.2022.5790

BibTeX
@article{Mulder2023,
  author = {Mulder, Michelle B and Duh, Quan-Yang},
  title = {Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?},
  journal = {JAMA Surgery},
  year = {2023},
  doi = {10.1001/jamasurg.2022.5790}
}
Kostenlos starten →